AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 83 filers reported holding AMYLYX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,244,382 | -15.1% | 2,962,555 | 0.0% | 0.22% | -16.0% |
| Q2 2023 | $63,902,311 | -26.5% | 2,962,555 | 0.0% | 0.26% | -35.8% |
| Q1 2023 | $86,921,364 | -49.2% | 2,962,555 | -36.1% | 0.41% | -52.4% |
| Q4 2022 | $171,248,692 | +5.4% | 4,634,606 | -19.7% | 0.86% | +14.3% |
| Q3 2022 | $162,441,000 | +17.6% | 5,770,536 | -19.5% | 0.75% | +18.7% |
| Q2 2022 | $138,105,000 | +49.9% | 7,170,536 | 0.0% | 0.63% | +69.4% |
| Q1 2022 | $92,141,000 | – | 7,170,536 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,088,333 | $224,963,904 | 6.32% |
| Alpha Wave Global, LP | 821,220 | $30,344,079 | 5.54% |
| Ghost Tree Capital, LLC | 350,000 | $12,933,000 | 5.52% |
| Boxer Capital, LLC | 2,084,000 | $77,003,800 | 4.06% |
| Altium Capital Management LP | 140,000 | $5,173,000 | 2.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,693,000 | $99,506,350 | 2.06% |
| Iron Triangle Partners LP | 240,240 | $8,876,868 | 1.59% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 655,015 | $24,202,804 | 1.50% |
| EMERALD ADVISERS, LLC | 836,909 | $30,923,788 | 1.49% |
| GREAT POINT PARTNERS LLC | 190,000 | $7,020,500 | 1.38% |